Angiotensin-receptor blockers and cancer: urgent regulatory review needed.
Nissen
Steven E
SE
D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D004335:Drug and Narcotic Control; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D018579:Patient Selection
D047228:Angiotensin II Type 1 Receptor Blockers